Inventor · disambiguated record
Matthew J. Chapin
Also filed as: CHAPIN MATTHEW · CHAPIN MATTHEW J · CHAPIN MATTHEW JONATHAN
10 granted patents·26 pending applications·30 citations·filing 2004–2021
87Inventor score
Files withACIEX THERAPEUTICS INC9NICOX OPHTHALMICS INC7OPHTHALMIC RES ASSOCIATES INC3ORA INC3OUSLER GEORGE W III3
Top patents by PatentIndex Score
36 records- 0189US10675279B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2018·Granted Jun 9, 2020·2 cites·8 claims
- 0287US8685439B2Method for the treatment and prevention of eyelid swellingCHAPIN MATTHEW JONATHAN·Filed 2007·Granted Apr 1, 2014·18 cites·3 claims
- 0383US9750684B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2015·Granted Sep 5, 2017·3 cites·4 claims
- 0481US9993471B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2017·Granted Jun 12, 2018·2 cites·6 claims
- 0581US9254286B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK B·Filed 2010·Granted Feb 9, 2016·4 cites·3 claims
- 0677US11918573B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2021·Granted Mar 5, 2024·0 cites·11 claims
- 0774US11617749B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 4, 2023·0 cites·5 claims
- 0873US10987352B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 27, 2021·0 cites·8 claims
- 0968US2014364475A1Compositions for the treatment and prevention of eyelid swellingACIEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1068US2021177807A1Compositions for the treatment and prevention of eyelid swellingNICOX OPHTHALMICS INC·Filed 2020·Application pending·0 cites
- 1164US8829005B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2013·Granted Sep 9, 2014·0 cites·8 claims
- 1264US2008261890A1Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditionsOUSLER GEORGE W·Filed 2008·Application pending·0 cites
- 1363US8569273B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK BARRY·Filed 2010·Granted Oct 29, 2013·1 cites·14 claims
- 1463US2009136598A1Compositions for the Treatment and Prevention of Eyelid SwellingACIEX INC·Filed 2008·Application pending·0 cites
- 1563US2017079957A1Compositions for the treatment and prevention of eyelid swellingNICOX OPHTHALMICS INC·Filed 2016·Application pending·0 cites
- 1662US2014343041A1Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine HeadacheORA INC·Filed 2014·Application pending·0 cites
- 1761US2018140612A1Topical ophthalmic formulations for the treatment and prevention of migraine headacheORA INC·Filed 2017·Application pending·0 cites
- 1860US2010130580A1Formulations and Methods for Treating Dry EyeACIEX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1958US2017042903A1Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine HeadacheORA INC·Filed 2016·Application pending·0 cites
- 2056US2009010850A1Formulations and methods for treating dry eyeOUSLER III GEORGE W·Filed 2008·Application pending·0 cites
- 2153US2004198828A1Combinational use of long-acting and short-acting anti-histamines for ocular allergiesFiled 2004·Application pending·0 cites
- 2252US2012021072A1Compositions For The Treatment And Prevention Of Eyelid SwellingCHAPIN MATTHEW JONATHAN·Filed 2011·Application pending·0 cites
- 2352US2014161903A1Compositions for the Treatment and Prevention of Eyelid SwellingACIEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2452US2006270592A1Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditionsOPHTHALMIC RES ASSOCIATES INC·Filed 2005·Application pending·0 cites
- 2549US2014045803A1Ophthalmic Formulations Of Cetirizine And Methods Of UseACIEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2647US2007254841A1Formulations and methods for treating dry eyeOPHTHALMIC RES ASSOCIATES INC·Filed 2007·Application pending·0 cites
- 2744US2008312194A1Methods and compositions for normalizing meibomian gland secretionsOUSLER III GEORGE W·Filed 2008·Application pending·0 cites
- 2844US2021052582A1Methods of use and pharmaceutical compositions of a selective syk inhibitorPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 2943US2005239745A1Novel topical ophthalmic formulationsOPHTHALMIC RES ASSOCIATES INC·Filed 2005·Application pending·0 cites
- 3042US2008039398A1Formulations and methods for treating dry eyeOUSLER GEORGE W III·Filed 2007·Application pending·0 cites
- 3142US2007297981A1Formulations and methods for treating dry eyeOUSLER GEORGE W III·Filed 2007·Application pending·0 cites
- 3242US2007299124A1Formulations and methods for treating dry eyeOUSLER GEORGE W III·Filed 2007·Application pending·0 cites
- 3340US2010311688A1Ophthalmic formulations, methods of manufacture, and methods of using sameACIEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3439US2012093876A1Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland SecretionsOUSLER III GEORGE W·Filed 2010·Application pending·0 cites
- 3534US2011105450A1Ophthalmic formulations of fluticasone and methods of useACIEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3633US2010240624A1Ophthalmic Formulations of Ketotifen and Methods of UseACIEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew J. Chapin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →